Momelotinib | CAS 1056634-68-4 - Request Quote
Momelotinib
| SZ CAT No: | SZ-M168001 |
| CAS No | 1056634-68-4 |
| Mol.F. | C23H22N6O2 |
| Mol.Wt. | 414.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1380317-28-1 (2HCl salt) : 1841094-16-3 (HCl salt) ; 1056636-08-8 (XHCl salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Momelotinib is chemically N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzamide. Momelotinib is supplied with detailed characterization data compliant with regulatory guideline. Momelotinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Momelotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1056634-68-4
Purchase 1056634-68-4
Order 1056634-68-4
Enquire 1056634-68-4
price of 1056634-68-4
1056634-68-4 Supplier
1056634-68-4 Manufacturer
1056634-68-4 Exporter
buy high quality Momelotinib
Purchase Momelotinib
Momelotinib suppliers
Momelotinib manufacturers
Momelotinib price
Order Momelotinib
Enquire Momelotinib
Momelotinib cost
Momelotinib Supplier
Momelotinib Distributor
Momelotinib for Method Validation
Momelotinib Reference Standard
Momelotinib for ANDA Filing
Momelotinib for Forced Degradation Studies
Momelotinib Identification Standards
Momelotinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


